![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, March 26, 2023 2:25:44 PM
a drug which causes the majority of those receiving it to experience either hypertensive crises or peripheral neuropathy, or very often both.
Hypertensive crises? Certainly with such a dangerous and scary crisis like this I am sure many who received Brilacidin would have to stop the test. But how many did? Look at your data.
Peripheral neuropathy? This also sounds super scary and serious.
"Nerve damage that causes pain, tingling, numbness, or weakness in the extremities is known as peripheral neuropathy, and it can cause impairment in sensation or both sensation and strength. It may affect a person’s ability to walk or participate fully in their everyday activities, which may negatively impact their quality of life."
https://www.yalemedicine.org/conditions/peripheral-neuropathy
Certainly persons in the ABSSSI test who had serious nerve damage from Brilacidin would have to stop the test. How many did? Look at your data.
Brilacidin did cause temporary numbness and tingling in some persons. Lidocaine also causes temporary numbness. Is it toxic? Should Lidocaine be considered dangerous and never used again?
Do you need a list of drugs that cause temporary tingling?
https://www.medindia.net/drugs/side-effects/paresthesia.htm
I would like entered in the record that the USA FDA has said it is okay to give Brilacidin to persons in the mouth and in the rectum and direct in the blood in other clinical trials. If Brilacidin was not safe in their opinion they would not allow this. I trust the USA FDA one million times more than anonymous persons in social media. The claim that Brilacidin is dangerous is false even it it appears almost every day. Repeating a lie does not make it truth.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM